Clinical Trial Update: A Randomized, Double-blind, Placebo- and Active-controlled Study of the Electric Current Effects of ABT-639 on the Spontaneous Activity of Pain Sensory Receptors in Patients With Diabetic Peripheral Neuropathy [Phase 2]

View source ↗

Summary

This is a Phase 2 randomized, double-blind trial evaluating ABT-639 for diabetic peripheral neuropathy to assess its effect on pain-related sensory receptor act…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Peripheral Neuropathy

Drugs mentioned

• ABT-639

Snippet

Sponsor: AbbVie (prior sponsor, Abbott) | Conditions: Diabetic Neuropathic Pain | Phase 2 | Status: COMPLETED